Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zinnat 250mg tablets
0501021K0BBABAB
|
Zinnat | Cefuroxime axetil | Infections | 19 |
|
Zinnat 125mg tablets
0501021K0BBAAAA
|
Zinnat | Cefuroxime axetil | Infections | 2 |
|
Zinnat 125mg/5ml oral suspension
0501021K0BBACAC
|
Zinnat | Cefuroxime axetil | Infections | 2 |
|
Zinnat Suspension 125mg granules sachets
0501021K0BBADAD
|
Zinnat | Cefuroxime axetil | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.